Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2216
https://www.valueinhealthjournal.com/article/S1098-3015(15)04292-8/fulltext
Title :
Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04292-8&doi=10.1016/j.jval.2015.09.2216
First page :
A628
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1627